Investigators evaluated the impact of acute psychosocial stress on changes in amygdala activation and functional connectivity among young adults with bipolar disorder.
Investigators conducted a systematic review and meta-analysis to assess the effect of pharmacotherapy on anxiety symptoms in individuals with bipolar disorder.
Investigators assessed the relationship between clinical and cognitive features and oddball neural deviations across the schizophrenia-bipolar spectrum.
A comparative list of psychotropic medications with their mood disorder indications (bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others).
Researchers conducted a meta-analysis of nearly 42,000 individuals with bipolar disorder and more than 370,000 control group participants.
The approval was based on data from 27 clinical studies, including the phase 3 ENLIGHTEN-1 and ENLIGHTEN-2 studies.
The sNDA submissions are supported by data from 2 global randomized, double-blind, placebo-controlled phase 3 studies.
This study looked at whether biomarkers can aid in the diagnosis of mood disorders as self-reporting or the clinical impression of a health care professional are not always reliable.
There may be an association between a history of psychiatric disorders in patients and age of onset of Alzheimer disease.
The researchers sought to estimate the age-specific incidence and prevalence of dementia diagnoses among older adults with schizophrenia in the United States compared to those without serious mental illness.
